<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Interleukin (IL)-1 is a pivotal proinflammatory cytokine consisting of two molecular species, IL-1α and IL-1β </plain></SENT>
<SENT sid="1" pm="."><plain>Anakinra (Kineret), a recombinant human IL-1 receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>, is regarded as a biological agent which blocks the inflammatory effects of IL-1 </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this review was to search the literatures and summarizes in vivo, in vitro and human studies on anakinra uses in <z:e sem="disease" ids="C0037274" disease_type="Disease or Syndrome" abbrv="">dermatological disorders</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The results show that anakinra is currently used clinically for the treatment of a variety of skin conditions such as <z:hpo ids='HP_0003765'>psoriasis</z:hpo>, <z:hpo ids='HP_0001047'>atopic dermatitis</z:hpo>, photoagaing, <z:hpo ids='HP_0002861'>melanoma</z:hpo>, <z:e sem="disease" ids="C0524988" disease_type="Disease or Syndrome" abbrv="">Schnitzler syndrome</z:e>, <z:hpo ids='HP_0000999'>pyoderma</z:hpo> gangraenosum, PAPA syndrome, <z:e sem="disease" ids="C0162836" disease_type="Disease or Syndrome" abbrv="">hidradenitis suppurativa</z:e>, lamellar <z:hpo ids='HP_0008064'>ichthyosis</z:hpo>, <z:e sem="disease" ids="C0085077" disease_type="Disease or Syndrome" abbrv="">Sweet's syndrome</z:e>, <z:mp ids='MP_0011164'>panniculitis</z:mp>, <z:e sem="disease" ids="C0268390" disease_type="Disease or Syndrome" abbrv="">Muckle-Wells syndrome</z:e>, familial Mediterranean <z:hpo ids='HP_0001945'>fever</z:hpo>, <z:e sem="disease" ids="C0263859" disease_type="Disease or Syndrome" abbrv="">SAPHO syndrome</z:e> and other disorders </plain></SENT>
<SENT sid="4" pm="."><plain>Notably, anakinra is expensive to produce and administer </plain></SENT>
<SENT sid="5" pm="."><plain>Injection is the route of therapy and allergic reaction is most possible </plain></SENT>
</text></document>